Monoclonal antibodies differentially affect the interaction between the hemagglutinin of H9 influenza virus escape mutants and sialic receptors

被引:15
|
作者
Ilyushina, N
Rudneva, I
Gambaryan, A
Bovin, N
Kaverin, N
机构
[1] DI Ivanovskii Inst Virol, Lab Virus Physiol, Moscow 123098, Russia
[2] Russian Acad Med Sci, MP Chumakov Inst Poliomyelitis & Viral Encephalit, Moscow 142782, Russia
[3] Shemyakin Bioorgan Chem Inst, Moscow 117997, Russia
基金
俄罗斯基础研究基金会;
关键词
influenza virus; hemagglutinin; monoclonal antibodies; receptor specificity; sialyloligosaccharides;
D O I
10.1016/j.virol.2004.08.002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To determine the receptor binding properties of various H9 influenza virus escape mutants in the presence and absence of antibody, sialyloligosaccharides conjugated with biotinylated polyacrylamide were used. A mutant virus with a L226Q substitution showed an increased affinity for the Neu5Acalpha2-3Galbeta1-4Glc. Several escape mutants viruses carrying the mutation N193D bound to Neu5Acalpha2-6Galbeta1-4GlcNAc considerably stronger than to Neu5Acalpha2-6Galbeta1-4Glc. Several monoclonal antibodies unable to neutralize the escape mutants preserved the ability to bind to the hemagglutinin as revealed by enzyme-linked immunosorbent assay. In each case, the bound monoclonal antibodies did not prevent the binding of the mutant HA to high affinity substrates and did not displace them from the virus binding sites. Together, these data suggest that amino acid changes selected by antibody pressure may be involved in the specificity of host-cell recognition by H9 hemagglutinin and in the ability of viruses with these mutations to escape the neutralizing effect of antibodies in a differential way, depending on the specificity of the host cell receptor. It may be important in the natural evolution of the H9 subtype, a plausible candidate for the agent likely to cause a future pandemic. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 50 条
  • [41] Characterization of Mouse Monoclonal Antibodies Against the HA of A(H7N9) Influenza Virus
    Ito, Mutsumi
    Yamayoshi, Seiya
    Murakami, Kazushi
    Saito, Kenji
    Motojima, Atsuo
    Nakaishi, Kazunari
    Kawaoka, Yoshihiro
    VIRUSES-BASEL, 2019, 11 (02):
  • [42] Pleiotropic effects of hemagglutinin amino acid substitutions of influenza A(H1N1)pdm09 virus escape mutants
    Rudneva, Irina A.
    Timofeeva, Tatiana A.
    Mukasheva, Evgenia A.
    Ignatieva, Anna V.
    Shilov, Aleksandr A.
    Burtseva, Elena I.
    Timofeev, Boris I.
    Kaverin, Nikolai V.
    VIRUS RESEARCH, 2018, 251 : 91 - 97
  • [43] MONOCLONAL AND MONOSPECIFIC ANTIBODIES IN DETERMINATIONS OF IMMUNODOMINANT ANTIGENIC SITES OF INFLUENZA-A (H3N2) VIRUS HEMAGGLUTININ
    ISAEVA, EI
    ROVNOVA, ZI
    PODCHERNYAEVA, RY
    VOPROSY VIRUSOLOGII, 1991, 36 (01) : 7 - 10
  • [44] Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus
    Lin, Xiantian
    Yang, Fan
    Yan, Sijing
    Wu, Han
    Wang, Ping
    Zhao, Yuxi
    Shi, Danrong
    Yao, Hangping
    Wu, Haibo
    Li, Lanjuan
    VIRUS RESEARCH, 2024, 345
  • [45] A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses
    Boonsathorn, Naphatsawan
    Panthong, Sumolrat
    Koksunan, Sarawut
    Chittaganpitch, Malinee
    Phuygun, Siripaporn
    Waicharoen, Sunthareeya
    Prachasupap, Apichai
    Sasaki, Tadahiro
    Kubota-Koketsu, Ritsuko
    Yasugi, Mayo
    Ono, Ken-ichiro
    Arai, Yasuha
    Kurosu, Takeshi
    Sawanpanyalert, Pathom
    Ikuta, Kazuyoshi
    Watanabe, Yohei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 452 (03) : 865 - 870
  • [46] Sialic Acid Recognition of the Pandemic Influenza 2009 H1N1 Virus: Binding Mechanism Between Human Receptor and Influenza Hemagglutinin
    Fukuzawa, Kaori
    Omagari, Katsumi
    Nakajima, Katsuhisa
    Nobusawa, Eri
    Tanaka, Shigenori
    PROTEIN AND PEPTIDE LETTERS, 2011, 18 (05): : 530 - 539
  • [47] Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy
    Kim, Se Mi
    Kim, Young-Il
    Park, Su-Jin
    Kim, Eun-Ha
    Kwon, Hyeok-Il
    Si, Young-Jae
    Lee, In-Won
    Song, Min-Suk
    Choi, Young Ki
    JOURNAL OF VIROLOGY, 2017, 91 (06)
  • [48] Presence of antibodies against H5, H7 and H9 influenza A virus in wild birds in the State of Sao Paulo, Brazil
    de Sousa, E.
    Costa, T. P.
    Werther, K.
    Durigon, E. L.
    de Araujo, J.
    Ferreira, C. S.
    Pinto, A. A.
    BRAZILIAN JOURNAL OF POULTRY SCIENCE, 2013, 15 (03) : 169 - 172
  • [49] Characterization of Neutralizing Monoclonal Antibodies and Identification of a Novel Conserved C-Terminal Linear Epitope on the Hemagglutinin Protein of the H9N2 Avian Influenza Virus
    Wang, Yanan
    Li, Xueyang
    Xu, Qianru
    Niu, Xiangxiang
    Zhang, Shenli
    Qu, Xiaotian
    Chu, Hongyan
    Chen, Jinxuan
    Shi, Qianqian
    Zhang, Erqin
    Zhang, Gaiping
    VIRUSES-BASEL, 2022, 14 (11):
  • [50] Efficacy of a recombinant turkey herpesvirus (H9) vaccine against H9N2 avian influenza virus in chickens with maternal-derived antibodies
    Pan, Xue
    Liu, Qinfang
    Niu, Shiqi
    Huang, Dongming
    Yan, Dawei
    Teng, Qiaoyang
    Li, Xuesong
    Beerens, Nancy
    Forlenza, Maria
    de Jong, Mart C. M.
    Li, Zejun
    FRONTIERS IN MICROBIOLOGY, 2023, 13